Search filters

List of works by Minetta C Liu

A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer

scientific article published on 01 November 2019

A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy.

scientific article published on 27 September 2012

Adaptive Randomization of Neratinib in Early Breast Cancer

scientific article published on July 2016

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer

scientific article published on July 2016

Adaptive Trials in the Neoadjuvant Setting: A Model to Safely Tailor Care While Accelerating Drug Development

scientific article published on 20 December 2012

Analysis of Cell-Free DNA to Assess Risk of Tumoremia Following Endoscopic Ultrasound Fine Needle Aspiration of Pancreatic Adenocarcinomas

scientific article published on 8 March 2018

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

scientific article

Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer

scientific article

Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing

scientific article published on 20 September 2018

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical T

scientific article published on 23 July 2020

Available and emerging molecular markers in the clinical management of breast cancer

scientific article published on 23 September 2019

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).

scientific article

By the numbers: does circulating tumor cell enumeration have a role in metastatic breast cancer?

scientific article published on 22 September 2014

Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity.

scientific article published on 26 December 2006

Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases

scientific article published on 29 March 2016

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).

scientific article published on 25 December 2011

Circulating Tumor DNA and Hepatocellular Carcinoma

scientific article published on 21 June 2019

Circulating tumor cell analysis in metastatic triple-negative breast cancers

scientific article published on 18 December 2014

Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma

scientific article

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

scientific article published on 14 September 2009

Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015

scientific article published on 06 May 2020

Considerations in the development of circulating tumor cell technology for clinical use ⬇️

scientific article published on July 2, 2012

Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients

scientific article published in March 2004

Detection of circulating tumor cells in high-risk endometrial cancer

scientific article

Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials ⬇️

scientific article published on March 7, 2013

Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses

scientific article published on May 2002

Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide follow

scientific article published on 30 January 2008

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

scientific article published on 13 February 2020

Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures.

scientific article

Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIAL

scientific article published on 16 August 2018

Fibromatosis of the breast after mammary prosthesis implantation.

scientific article published in September 2008

First-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial

scientific article published on 12 December 2019

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

scientific article published on 30 August 2017

Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients

scientific article published on 04 February 2020

Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells

scientific article published on March 2009

Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer

scientific article published on 14 September 2017

Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform Cancer Therapy

scientific article published on 02 November 2019

Liquid Biopsy: Emergence of an Alternative Cancer Detection Method

scientific article published on 31 March 2020

Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial) ⬇️

scientific article published on July 28, 2011

Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer

scientific article published in February 2009

NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

scientific article published on 15 December 2021

NOTCH3 expression is linked to breast cancer seeding and distant metastasis

scientific article published on 04 September 2018

Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship.

scientific article published on 16 April 2013

Oncolytic Measles Virotherapy and Opposition to Measles Vaccination

scientific article published on 22 June 2019

P53 gene mutations: case study of a clinical marker for solid tumors

scientific article

PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).

scientific article

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

scientific article

Phase 2 study of pembrolizumab as first-line therapy for PD-L1–positive metastatic triple-negative breast cancer (mTNBC): Preliminary data from KEYNOTE-086 cohort B

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer.

scientific article published on 30 December 2017

Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer ⬇️

scientific article published on October 26, 2010

Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer ⬇️

scientific article published on August 21, 2013

Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma

scientific article published on 11 December 2019

Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer

scientific article published in April 2008

Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013

scientific article published on 21 March 2016

Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers

scientific article published on 20 July 2016

Real-time imaging and characterization of human breast tissue by reflectance confocal microscopy.

scientific article published on September 2007

STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective Trial

scientific article published on 05 November 2020

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

scientific article

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer

scientific article

TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

scientific article published on 18 February 2020

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.

scientific article

TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer.

scientific article published on 16 March 2015

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

scientific article

TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer

scientific article published 2019

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer

scientific article published on 24 February 2015

The properties of high-dimensional data spaces: implications for exploring gene and protein expression data.

scientific article

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

scientific article published on February 2016

Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms

scientific article published on 29 January 2019

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx

scientific article published on 31 May 2019

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

scientific article

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

scientific article published on 10 July 2017

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

scientific article

Paulina is supported by:

About Paulina

Help